Literature DB >> 35138469

Exosomal circ_0001190 Regulates the Progression of Gastric Cancer via miR-586/SOSTDC1 Axis.

Chao Liu1, Jing Yang2, Fengchi Zhu2, Zhiying Zhao1, Lixue Gao3.   

Abstract

Gastric cancer (GC) is the fifth most common cancer, which has a significant impact on human health. Recent researches have shown that circular RNAs (circRNAs) could affect the progress of GC, but the mechanism still indistinct. In this work, we explored the roles of circ_0001190 in GC. The levels of circ_0001190, microRNA-586 (miR-586) and sclerostin domain containing 1 (SOSTDC1) were detected by quantitative RT-PCR and western blot in GC. The cell functions were scrutinized by cell counting kit-8 assay, 5-Ethynyl-29-deoxyuridine assay, flow cytometry assay, tube formation assay, transwell assay, and western blot. Furthermore, the relationship between miR-586 and circ_0001190 or SOSTDC1 was identified by dual-luciferase reporter assay. Finally, the xenograft model test was implemented to demonstrate the effect of exosomal circ_0001190 in vivo. The levels of circ_0001190 and SOSTDC1 were downregulated, and the miR-586 level was increased in GC. For functional assay, circ _0001190 overexpression inhibited cell vitality, cell proliferation, angiogenesis, cell migration and invasion, whereas stimulated cell apoptosis in GC cells. Circ _0001190 served as a miR-586 sponge to adjust the expression of SOSTDC1. Additionally, miR-586 could promote the advancement of GC by interfering SOSTDC1. Exosomal circ_0001190 overexpression inhibited the development of GC by miR-586/SOSTDC1 axis, which proposed a potential targeted therapy for GC cure.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Exosomal circ_0001190; Gastric cancer; SOSTDC1; miR-586

Year:  2022        PMID: 35138469     DOI: 10.1007/s10528-021-10180-6

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  40 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.

Authors:  Youngwook Ahn; Carrie Sims; Megan J Murray; Paige K Kuhlmann; Jesús Fuentes-Antrás; Scott D Weatherbee; Robb Krumlauf
Journal:  Development       Date:  2017-07-10       Impact factor: 6.868

Review 3.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

4.  The BMP antagonist, SOSTDC1, restrains gastric cancer progression via inactivation of c-Jun signaling.

Authors:  Yuzhu Cui; Feifei Zhang; Yongxu Jia; Liangzhan Sun; Miao Chen; Shayi Wu; Krista Verhoeft; Yan Li; Yanru Qin; Xinyuan Guan; Ka-On Lam
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

5.  Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Authors:  Claudia Allemani; Tomohiro Matsuda; Veronica Di Carlo; Rhea Harewood; Melissa Matz; Maja Nikšić; Audrey Bonaventure; Mikhail Valkov; Christopher J Johnson; Jacques Estève; Olufemi J Ogunbiyi; Gulnar Azevedo E Silva; Wan-Qing Chen; Sultan Eser; Gerda Engholm; Charles A Stiller; Alain Monnereau; Ryan R Woods; Otto Visser; Gek Hsiang Lim; Joanne Aitken; Hannah K Weir; Michel P Coleman
Journal:  Lancet       Date:  2018-01-31       Impact factor: 79.321

6.  A human bone morphogenetic protein antagonist is down-regulated in renal cancer.

Authors:  Kimberly Rose Blish; Wei Wang; Mark C Willingham; Wei Du; Charles E Birse; Surekha R Krishnan; Julie C Brown; Gregory A Hawkins; A Julian Garvin; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Mol Biol Cell       Date:  2007-11-21       Impact factor: 4.138

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target.

Authors:  Guanghui Chen; Haiyi Gong; Ting Wang; Jian Wang; Zhitao Han; Guangjian Bai; Shuai Han; Xinghai Yang; Wang Zhou; Tielong Liu; Jianru Xiao
Journal:  Int J Mol Med       Date:  2018-10-10       Impact factor: 4.101

9.  Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4.

Authors:  Lixian Ding; Yuying Zhao; Shuwei Dang; Yue Wang; Xinglong Li; Xiaotong Yu; Zhongsheng Li; Jiufeng Wei; Ming Liu; Guodong Li
Journal:  Mol Cancer       Date:  2019-03-28       Impact factor: 27.401

10.  SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.

Authors:  Rubén A Bartolomé; Laura Pintado-Berninches; Marta Jaén; Vivian de Los Ríos; Juan Ignacio Imbaud; J Ignacio Casal
Journal:  Oncogene       Date:  2020-08-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.